Maximum Strength Guaifenesin DM
- Product NDC
- 0536-1213
- 11-digit product format
- 005361213
- Labeler code
- 0536
- Product ID
- 0536-1213_74767680-e4e7-4ba6-8d45-a01cd0471317
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin, Dextromethorphan HBr
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Rugby Laboratories
- Application
- ANDA209692
- Marketing category
- ANDA
- Marketing start
- 2018-11-05
- Marketing end
- 2026-09-28
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 60; 1200 mg/1; mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209692-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-11-01 | ||
| A209692-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-11-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209692-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-11-01 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A209692-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-11-01 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucus Relief DM Extended Release Caplets | GUAIFENESIN, DEXTROMETHORPHAN HBR | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 3850544d-0d25-429e-98a9-5c4ad6cfd222 | 2026-07-14 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Best Choice (Valu Merchandisers Company) | 6d454e89-59ce-40dc-b0d2-3330a7df519f | 2026-04-15 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Best Choice (Valu Merchandisers Company) | 344de7bb-de3b-4c15-a920-72d94e5e0e9f | 2026-03-18 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | CVS Pharmacy | 59c338a0-8dc9-43a7-b8df-c26ae475def3 | 2026-03-18 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | CARDINAL HEALTH 110, LLC. DBA LEADER 70000 | e24fd894-5dee-4f46-aafa-fbf9f0b166fd | 2026-02-10 | Warnings | 209692 ANDA209692 |
| Maximum Strength Guaifenesin DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Rugby Laboratories | 2c9515f8-3120-4dbb-a7fc-d89fc5727148 | 2026-02-10 | Warnings | 209692 ANDA209692 0536-1213 |
| Mucus Relief DM Extended Release Caplets | GUAIFENESIN, DEXTROMETHORPHAN HBR | Rugby Laboratories | 69cd399a-0103-4543-bb06-c7cccffe9cc4 | 2026-02-10 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | P & L Development, LLC | a397799d-46a6-447b-9498-17436d218e29 | 2026-01-28 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 2426bf76-19bf-4bfd-8f9e-3b348e4b5641 | 2025-11-11 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Family Dollar (FAMILY WELLNESS) | ebc1a915-f643-4878-9d7a-67a9c6a26b20 | 2025-10-30 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Family Dollar (FAMILY WELLNESS) | b60d1cc6-086c-4483-a101-c5f8d6000969 | 2025-10-29 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM Extended Release Caplets | GUAIFENESIN, DEXTROMETHORPHAN HBR | Walgreens | be5ab61a-abd6-4dee-9607-2f1e2c47b2dc | 2025-08-28 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM Extended Release Caplets Maximum Strength | GUAIFENESIN, DEXTROMETHORPHAN HBR | Walgreens | 11310cf8-ea34-47a2-b4d7-fe1131fef462 | 2025-08-28 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM Maximum Strength | GUAIFENESIN, DEXTROMETHORPHAN HBR | Rite Aid Corporation | 8467474f-6278-47d9-8228-451d08ddf983 | 2025-08-20 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Rite Aid Corporation | 035693ed-d720-430b-98f5-fe4b5dec5db6 | 2025-08-20 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM Maximum Strength | GUAIFENESIN, DEXTROMETHORPHAN HBR | Chain Drug Consortium, LLC | d6aae1a1-0ab9-4b26-9f62-b8761014bb35 | 2025-06-30 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM Extended Release Caplets | GUAIFENESIN, DEXTROMETHORPHAN HBR | ATLANTIC BIOLOGICALS CORP. | 308f50dd-e8d6-0264-e063-6394a90afa68 | 2025-06-27 | Warnings | 209692 ANDA209692 |
| Guaifenesin and Dextromethorphan HBr | GUAIFENESIN AND DEXTROMETHORPHAN HBR | Amneal Pharmaceuticals LLC | 5760a828-1c28-4272-a7b7-ac98466aa294 | 2024-10-25 | Warnings | 209692 ANDA209692 |
| Guaifenesin and Dextromethorphan HBr | GUAIFENESIN AND DEXTROMETHORPHAN HBR | Amneal Pharmaceuticals LLC | cfdbcdb0-531a-4d95-ac5d-64d6d034b252 | 2024-10-25 | Warnings | 209692 ANDA209692 |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | H E B | 20df2ffe-5281-4cd6-adb3-3a3d28788ef6 | 2024-08-02 | Warnings | 209692 ANDA209692 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Maximum Strength Guaifenesin DM
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 60 mg/1 |
| GUAIFENESIN | 1200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1099074 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2c9515f8-3120-4dbb-a7fc-d89fc5727148 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf324df6-7127-7deb-def5-2681c136cd03 | Product name | 3 | 20250325 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0536-1213-88 | Maximum Strength Guaifenesin DM | 14 in 1 CARTON | TABLET, EXTENDED RELEASE | 14 | 9 | |
| 0536-1213-88 | Maximum Strength Guaifenesin DM | 1 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 1 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0536-1213-88 | EA - Each | 0536-1213 | c8d59758-c58c-48ac-9ab2-ad82cf5db476 | 1 | 2018-12-13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0536-1213 | MAXIMUM STRENGTH GUAIFENESIN DM (GUAIFENESIN, DEXTROMETHORPHAN HBR) TABLET, EXTENDED RELEASE [RUGBY LABORATORIES, INC.] | 8 | Current NDC, Legacy NDC, 2 package rows | 20250327_2c9515f8-3120-4dbb-a7fc-d89fc5727148.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1099074 | guaiFENesin 1200 MG / dextromethorphan HBr 60 MG 12HR Extended Release Oral Tablet | PSN | 2c9515f8-3120-4dbb-a7fc-d89fc5727148 | 9 |
| 1099074 | 12 HR dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG Extended Release Oral Tablet | SCD | 2c9515f8-3120-4dbb-a7fc-d89fc5727148 | 9 |
| 1099074 | dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG 12 HR Extended Release Oral Tablet | SY | 2c9515f8-3120-4dbb-a7fc-d89fc5727148 | 9 |
| 1099074 | guaiFENesin 1200 MG / dextromethorphan HBr 60 MG 12HR Extended Release Oral Tablet | PSN | 786607e9-ee2d-4510-8556-857032e4053f | 3 |
| 1099074 | 12 HR dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG Extended Release Oral Tablet | SCD | 786607e9-ee2d-4510-8556-857032e4053f | 3 |
| 1099074 | dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG 12 HR Extended Release Oral Tablet | SY | 786607e9-ee2d-4510-8556-857032e4053f | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0536-1213-88 | 00536121388 | 14 BLISTER PACK in 1 CARTON (0536-1213-88) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 14 blister pack | 2018-11-05 | 2026-09-28 | No | No | Current |